AI edge devices fuel interest: Social media chatter highlights Enovix's silicon-anode battery architecture as a potential solution for powering next-generation wearables and sensors in the expanding AI ecosystem, where compact energy density is becoming critical.
Manufacturing hurdles noted: Discussions point to ongoing challenges in scaling production at facilities like Fab2, with observers emphasizing that successful customer qualifications and volume output will determine whether the technology moves beyond development agreements.
Sentiment remains divided: Some view the AI tailwind as a meaningful catalyst, while others stress execution risks and the gap between promising specs and reliable, cost-effective supply.
Note: This discussion summary was generated from an AI condensation of post data.
Enovix Insider Trading Activity
Enovix insiders have traded $ENVX stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $ENVX stock by insiders over the last 6 months:
- KRISTINA TRUONG (Chief Accounting Officer) sold 2,296 shares for an estimated $16,783
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
Enovix Revenue
Enovix had revenues of $11.3M in Q4 2025. This is an increase of 15.93% from the same period in the prior year.
You can track ENVX financials on Quiver Quantitative's ENVX stock page.
You can access data on ENVX stock through the Quiver Quantitative API.
Enovix Hedge Fund Activity
We have seen 148 institutional investors add shares of Enovix stock to their portfolio, and 194 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MILLENNIUM MANAGEMENT LLC added 2,026,634 shares (+2186.8%) to their portfolio in Q1 2026, for an estimated $10,497,964
- VANGUARD GROUP INC added 1,747,145 shares (+10.9%) to their portfolio in Q4 2025, for an estimated $12,771,629
- ELECTRON CAPITAL PARTNERS, LLC removed 1,425,734 shares (-23.6%) from their portfolio in Q1 2026, for an estimated $7,385,302
- BLACKROCK, INC. added 1,280,739 shares (+9.1%) to their portfolio in Q1 2026, for an estimated $6,634,228
- MORGAN STANLEY removed 1,280,610 shares (-41.4%) from their portfolio in Q1 2026, for an estimated $6,633,559
- CENTERBOOK PARTNERS LP added 1,183,585 shares (+67.3%) to their portfolio in Q1 2026, for an estimated $6,130,970
- D. E. SHAW & CO., INC. removed 922,944 shares (-89.9%) from their portfolio in Q4 2025, for an estimated $6,746,720
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
Enovix Analyst Ratings
Wall Street analysts have issued reports on $ENVX in the last several months. We have seen 0 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- JP Morgan issued a "Underweight" rating on 05/06/2026
To track analyst ratings and price targets for Enovix, check out Quiver Quantitative's $ENVX forecast page.
Enovix Price Targets
Multiple analysts have issued price targets for $ENVX recently. We have seen 6 analysts offer price targets for $ENVX in the last 6 months, with a median target of $11.5.
Here are some recent targets:
- Mickey Legg from Benchmark set a target price of $15.0 on 05/14/2026
- Anthony Stoss from Craig-Hallum set a target price of $8.0 on 05/14/2026
- Jeff Osborne from TD Cowen set a target price of $7.0 on 05/14/2026
- Colin Rusch from Oppenheimer set a target price of $21.0 on 05/14/2026
- Ruplu Bhattacharya from B of A Securities set a target price of $6.0 on 03/12/2026
- George Gianarikas from Canaccord Genuity set a target price of $15.0 on 02/26/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.